InnoCare Optoelectronics (6861) Investor presentation summary
Event summary combining transcript, slides, and related documents.
Investor presentation summary
10 Sep, 20261H 2026 operational summary
Product mix shifted toward higher-value, high-margin ODM modules, boosting profitability.
Revenue from emerging markets, especially India, grew rapidly due to local initiatives.
Multiple new projects reached stable mass production, driving profit growth.
Strategic inventory preparation supports customer shipments through 2028.
Plant relocation progress and Indian market growth
Plant relocation plan ensures uninterrupted customer supply, with safety stock coverage through 2028.
"Make in India" initiatives and local partnerships drive sustainable growth in India.
Indian market growth fueled by policy support, national TB screening, and telemedicine expansion.
Local manufacturing and regulatory execution accelerate compliance and tender success.
Industrial inspection technology & application updates
Expanded high-end industrial detector line for NDT, battery, and semiconductor applications.
Solutions support advanced packaging, PCBA, SMT, and large panel inspections.
High precision and high penetration imaging targets Al server, DRAM, and TGV inspection.
Tier 1 and Tier 2 customer qualifications completed for key components.
Latest events from InnoCare Optoelectronics
- Q2 115 net income surged 202% year-over-year on 37% revenue growth and stable margins.6861
Q2 2026 - Q2 115 revenue grew 37% and net income rose 202% year-over-year, with robust margins.6861
Q1 2026 - Q2 2024 saw double-digit revenue and profit growth, improved margins, and a cash dividend payout.6861
Q2 2024 - Q3 2023 revenue rose 19% YoY to NT$483.7M, with net income of NT$30.9M and EPS of NT$0.75.6861
Q3 2024 - Revenue and net income rose sharply year-over-year, with improved margins and strong cash flow.6861
Q4 2024 - Q1 2024 saw 17% revenue growth and doubled net income, with EPS up to NT$1.03.6861
Q1 2025 - Revenue up 12% year-over-year, net income at NT$74.9M, gross margin steady at 28%.6861
Q2 2025 - Revenue up 13% year-over-year, but net income down 7% as margins narrowed.6861
Q3 2025 - Revenue rose 15% to NT$2.29B, net income up 4%, and EPS reached NT$3.84.6861
Q4 2025